• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Explaining the "Unexpectedly High" Frequency of Invasive Fungal Disease in a Cohort Study of Solid Organ Transplant Recipients Treated With Belatacept.在一项接受贝拉西普治疗的实体器官移植受者队列研究中，解释侵袭性真菌病“意外高”的发生率
Open Forum Infect Dis. 2024 May 20;11(6):ofae291. doi: 10.1093/ofid/ofae291. eCollection 2024 Jun.
2
An Unexpectedly High Incidence of Invasive Fungal Diseases in Solid Organ Transplant Recipients Taking Belatacept for Organ Rejection Prophylaxis: A Single-Center Retrospective Cohort Study.接受贝拉西普预防器官排斥的实体器官移植受者侵袭性真菌病的意外高发病率：一项单中心回顾性队列研究
Open Forum Infect Dis. 2024 Mar 16;11(6):ofae158. doi: 10.1093/ofid/ofae158. eCollection 2024 Jun.
3
Belatacept for kidney transplant recipients.用于肾移植受者的贝拉西普。
Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD010699. doi: 10.1002/14651858.CD010699.pub2.
4
Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high-risk cytomegalovirus serostatus kidney transplant recipients.贝拉西普和他克莫司对中高危巨细胞病毒血清学状态肾移植受者病毒载量控制和复发的影响。
Transpl Infect Dis. 2022 Dec;24(6):e13983. doi: 10.1111/tid.13983. Epub 2022 Nov 14.
5
A case report of a lung transplant recipient receiving belatacept in combination with low dose tacrolimus complicated by progressive multifocal leukoencephalopathy.一例肺移植受者接受贝拉西普联合低剂量他克莫司治疗并发进行性多灶性白质脑病的病例报告。
Respir Med Case Rep. 2024 Apr 28;49:102028. doi: 10.1016/j.rmcr.2024.102028. eCollection 2024.
6
Long-term Safety in Epstein-Barr Virus-Seropositive Kidney-only Transplant Recipients Treated With Belatacept in Clinical Practice: Final Study Results From the ENLiST Registry.在临床实践中接受贝拉西普治疗的爱泼斯坦-巴尔病毒血清阳性仅肾移植受者的长期安全性：ENLiST注册研究的最终结果
Transplant Direct. 2024 May 17;10(6):e1644. doi: 10.1097/TXD.0000000000001644. eCollection 2024 Jun.
7
Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).固体器官移植受者真菌感染伊曲康唑治疗的安全性和有效性（ISASOT 研究）。
Microbiol Spectr. 2022 Feb 23;10(1):e0178421. doi: 10.1128/spectrum.01784-21. Epub 2022 Feb 16.
8
Humoral and Cellular Immune Responses of Solid Organ Transplant Patients on Belatacept to Three Doses of mRNA-Based Anti-SARS-CoV-2 Vaccine.接受贝拉西普治疗的实体器官移植患者对三剂基于mRNA的抗SARS-CoV-2疫苗的体液免疫和细胞免疫反应
Vaccines (Basel). 2022 Feb 24;10(3):354. doi: 10.3390/vaccines10030354.
9
Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients administered belatacept or cyclosporine in BENEFIT and BENEFIT-EXT.在 BENEFIT 和 BENEFIT-EXT 试验中，接受贝利尤单抗或环孢素治疗的黑人与非黑人肾移植受者，移植后 7 年的结局。
Clin Transplant. 2018 Apr;32(4):e13225. doi: 10.1111/ctr.13225. Epub 2018 Mar 14.
10
Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update.贝拉西普预防肾移植成年患者急性排斥反应的最新进展
Biologics. 2012;6:385-93. doi: 10.2147/BTT.S23561. Epub 2012 Nov 2.

引用本文的文献

1
Epidemiology of Infections in Lung Transplant Recipients Treated With Belatacept.接受贝拉西普治疗的肺移植受者感染的流行病学
Transpl Infect Dis. 2025 Jan-Feb;27(1):e14403. doi: 10.1111/tid.14403. Epub 2024 Nov 4.
2
Reply to Heldman et al.对赫尔德曼等人的回复
Open Forum Infect Dis. 2024 May 20;11(6):ofae292. doi: 10.1093/ofid/ofae292. eCollection 2024 Jun.

本文引用的文献

1
An Unexpectedly High Incidence of Invasive Fungal Diseases in Solid Organ Transplant Recipients Taking Belatacept for Organ Rejection Prophylaxis: A Single-Center Retrospective Cohort Study.接受贝拉西普预防器官排斥的实体器官移植受者侵袭性真菌病的意外高发病率：一项单中心回顾性队列研究
Open Forum Infect Dis. 2024 Mar 16;11(6):ofae158. doi: 10.1093/ofid/ofae158. eCollection 2024 Jun.
2
Fungal Infections and Colonization after Bilateral Lung Transplant: A Six-Year Single-Center Experience.双侧肺移植后的真菌感染与定植：一项为期六年的单中心经验
J Fungi (Basel). 2024 Jan 19;10(1):80. doi: 10.3390/jof10010080.
3
Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study.瑞士器官移植队列研究：实体器官移植后第一年感染性疾病的负担和时间进程。
Clin Infect Dis. 2020 Oct 23;71(7):e159-e169. doi: 10.1093/cid/ciz1113.
4
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.侵袭性真菌病的共识定义修订与更新：来自欧洲癌症研究与治疗组织和真菌病研究组教育与研究联合会。
Clin Infect Dis. 2020 Sep 12;71(6):1367-1376. doi: 10.1093/cid/ciz1008.
5
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).器官移植受者中的侵袭性真菌感染：移植相关感染监测网络（TRANSNET）的结果。
Clin Infect Dis. 2010 Apr 15;50(8):1101-11. doi: 10.1086/651262.
6
Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.实体器官移植受者侵袭性真菌感染的流行病学及结局
Transpl Infect Dis. 2010 Jun;12(3):220-9. doi: 10.1111/j.1399-3062.2010.00492.x. Epub 2010 Jan 25.
7
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.欧洲癌症研究与治疗组织/侵袭性真菌感染合作组和美国国立过敏与传染病研究所真菌病研究组（EORTC/MSG）共识组对侵袭性真菌病的修订定义。
Clin Infect Dis. 2008 Jun 15;46(12):1813-21. doi: 10.1086/588660.
8
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.定义癌症和造血干细胞移植免疫受损患者中的机会性侵袭性真菌感染：一项国际共识。
Clin Infect Dis. 2002 Jan 1;34(1):7-14. doi: 10.1086/323335. Epub 2001 Nov 26.
9
Aspergillus airway colonization and invasive disease after lung transplantation.肺移植术后曲霉菌气道定植与侵袭性疾病
Chest. 1997 Nov 5;112(5):1160-4. doi: 10.1378/chest.112.5.1160.

Explaining the "Unexpectedly High" Frequency of Invasive Fungal Disease in a Cohort Study of Solid Organ Transplant Recipients Treated With Belatacept.

作者信息

Heldman Madeleine R, Alexander Barbara D, Perfect John R, Schwartz Ilan S, Maziarz Eileen K

机构信息

Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

出版信息

Open Forum Infect Dis. 2024 May 20;11(6):ofae291. doi: 10.1093/ofid/ofae291. eCollection 2024 Jun.

DOI:10.1093/ofid/ofae291
PMID:38854396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11161895/
Abstract
摘要